Generex Biotechnology Corporation's stock has declined approximately -99.13043% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.13043% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Generex Biotechnology Corporation's most recent stock split took place on February 25, 2020 with a 5:7 split ratio.
| Last Split Date | 2/25/2020 |
| Split Ratio | 5:7 |